Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

<div>Representative staining of SGLT1 in different subtypes of breast cancer (×100, ×400). (a) Negative immunoreactions. Scale bar: 100 <i>μ</i>m. (b) Positive staining of SGLT1 in luminal-like breast cancer. (c) Positive staining of SGLT1 in HER2+ breast cancer. (d) Positive staining of SGLT1 in basal-like breast cancer.</div>

Disease Markers

fig1

Figure 1

Figure 1: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer 

Figure 1 | Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer 